2 results match your criteria: "WHO Collaborating Center (DPB); and Center for Primary and Community Care[Affiliation]"
Am J Phys Med Rehabil
November 2024
From the Department of Health Science and Medicine, University of Lucerne, Lucerne, Switzerland (DPB, AG); Swiss Paraplegic Research, Nottwil, Switzerland (DPB, AO, MB); Center for Rehabilitation in Global Health Systems, WHO Collaborating Center (DPB); and Center for Primary and Community Care, Lucerne, Switzerland (AG).
Objective: The aim of the study is to investigate healthcare utilization and related costs in spinal cord injury compared to the Swiss population, addressing gaps in understanding this vulnerable group's needs.
Design: We analyzed healthcare utilization across age groups using data from the Swiss Health Survey and the Swiss Community Survey. Employing count models, Zero-Inflated Negative Binomial, and Poisson regressions, we estimated the adjusted healthcare visits across different age groups in the sample.
Vaccine X
December 2023
Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut (FLI), WHO Collaborating Centre for Rabies Surveillance and Research, 17493 Greifswald-Insel Riems, Germany.
In a long-term immunogenicity study (1100 days post vaccination) in local Thai dogs the immune response of the oral rabies vaccine SPBN GASGAS was compared to those elicited by a commercial inactivated vaccine using immunobridging. Based on the detection of rabies virus binding (rVBA) and rabies virus neutralizing antibodies (rVNA) as measured by ELISA and Rapid Fluorescent Focus Inhibition Test (RFFIT) the long-term immune response in dogs vaccinated orally with the SPBNA GASGAS strain of rabies vaccine in a bait was non-inferior to a conventional inactivated rabies vaccine. The outcome of this study supports extending the originally claimed duration of immunity (DOI) of SPBN GASGAS after oral vaccination for dogs from 6 to 30 months.
View Article and Find Full Text PDF